Rispens T - Search Results

1

Restricted immune activation and internalisation of anti-idiotype complexes between drug and antidrug antibodies.

van Schie KA, Kruithof S, Ooijevaar-de Heer P, Derksen NIL, van de Bovenkamp FS, Saris A, Vidarsson G, Bentlage AEH, Jiskoot W, Romeijn S, Koning RI, Bos E, Stork EM, Koeleman CAM, Wuhrer M, Wolbink G, Rispens T. van Schie KA, et al. Among authors: rispens t. Ann Rheum Dis. 2018 Oct;77(10):1471-1479. doi: 10.1136/annrheumdis-2018-213299. Epub 2018 Jun 26. Ann Rheum Dis. 2018. PMID: 29945923

2

Detection of conformational changes in immunoglobulin G using isothermal titration calorimetry with low-molecular-weight probes.

Rispens T, Lakemond CM, Derksen NI, Aalberse RC. Rispens T, et al. Anal Biochem. 2008 Sep 15;380(2):303-9. doi: 10.1016/j.ab.2008.06.001. Epub 2008 Jun 5. Anal Biochem. 2008. PMID: 18577365

3

Probing bis-ANS binding sites of different affinity on aggregated IgG by steady-state fluorescence, time-resolved fluorescence and isothermal titration calorimetry.

Hawe A, Rispens T, Herron JN, Jiskoot W. Hawe A, et al. Among authors: rispens t. J Pharm Sci. 2011 Apr;100(4):1294-305. doi: 10.1002/jps.22368. Epub 2010 Oct 18. J Pharm Sci. 2011. PMID: 20957745

4

Mechanism of immunoglobulin G4 Fab-arm exchange.

Rispens T, Ooijevaar-de Heer P, Bende O, Aalberse RC. Rispens T, et al. J Am Chem Soc. 2011 Jul 6;133(26):10302-11. doi: 10.1021/ja203638y. Epub 2011 Jun 15. J Am Chem Soc. 2011. PMID: 21627172

5

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.

Guhr T, Bloem J, Derksen NI, Wuhrer M, Koenderman AH, Aalberse RC, Rispens T. Guhr T, et al. Among authors: rispens t. PLoS One. 2011;6(6):e21246. doi: 10.1371/journal.pone.0021246. Epub 2011 Jun 23. PLoS One. 2011. PMID: 21731683 Free PMC article.

6

Use of a human recombinant immunoglobulin G1 CH3 domain as a probe for detecting alternatively folded human IgG in intravenous Ig products.

Guhr T, Derksen N, Aalberse R, Rispens T. Guhr T, et al. Among authors: rispens t. J Pharm Sci. 2012 Mar;101(3):978-86. doi: 10.1002/jps.22828. Epub 2011 Nov 18. J Pharm Sci. 2012. PMID: 22102504

7

Immunogenicity of biological therapeutics: from assay to patient.

Krieckaert C, Rispens T, Wolbink G. Krieckaert C, et al. Among authors: rispens t. Curr Opin Rheumatol. 2012 May;24(3):306-11. doi: 10.1097/BOR.0b013e3283521c4e. Curr Opin Rheumatol. 2012. PMID: 22388644 Review.

8

Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.

van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EE, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Among authors: rispens t. Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3. Ann Rheum Dis. 2013. PMID: 22759910

9

Fc-Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer.

Rispens T, Meesters J, den Bleker TH, Ooijevaar-De Heer P, Schuurman J, Parren PW, Labrijn A, Aalberse RC. Rispens T, et al. Mol Immunol. 2013 Jan;53(1-2):35-42. doi: 10.1016/j.molimm.2012.06.012. Epub 2012 Jul 10. Mol Immunol. 2013. PMID: 22784992

10

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.

Vennegoor A, Rispens T, Strijbis EM, Seewann A, Uitdehaag BM, Balk LJ, Barkhof F, Polman CH, Wolbink G, Killestein J. Vennegoor A, et al. Among authors: rispens t. Mult Scler. 2013 Apr;19(5):593-600. doi: 10.1177/1352458512460604. Epub 2012 Sep 19. Mult Scler. 2013. PMID: 22992450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page